Q4 2024 NeueHealth Inc Earnings Call Transcript
Key Points
- NeueHealth Inc (NEUE) reported its strongest financial performance to date in 2024, with a full year consolidated revenue of $936.7 million.
- The company achieved adjusted EBITDA profitability for the fourth consecutive quarter, with $5.5 million in Q4 and $22.5 million for the full year.
- NeueHealth Inc (NEUE) experienced significant consumer growth, serving 483,000 consumers in 2024, representing a compound annual growth rate of 123% since 2020.
- The company expanded its operations in Central Florida and secured new payer partnerships, demonstrating strong strategic growth opportunities.
- NeueHealth Inc (NEUE) is set to become a privately held company through an acquisition by an affiliate of NEA, positioning it for continued growth with increased flexibility and resources.
- The NeueSolutions segment reported an operating loss of $5.3 million for the full year, despite generating $635.1 million in revenue.
- The company faces risks and uncertainties that could cause actual results to differ materially from expectations, as highlighted in their SEC filings.
- Despite growth, the company still has a significant amount of restricted cash and investments, totaling $36.3 million.
- The transition to becoming a privately held company may involve uncertainties and challenges related to the acquisition process.
- NeueHealth Inc (NEUE) continues to operate in a highly competitive healthcare industry, which may impact its ability to maintain growth and profitability.
Good morning and thank you for joining us for the NeueHealth Q4 2024 earnings conference call. My name is Carly and I'll be coordinating the call today. And I'd like to hand over to your host, Emily Lombardi. The floor is yours.
Good morning, and welcome to NeueHealth's fourth-quarter 2024 earnings conference call. As a reminder, this call is being recorded. Leading the call today are NeueHealth's President and CEO, Mike Mikan; and CFO, Jay Matushak. Before we begin, we want to remind you that this call may contain forward-looking statements under US federal securities laws.
These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the reports that we file with the Securities and Exchange Commission, including the risk factors in our current and periodic reports we file with the SEC.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
